Guiding screening programs with polygenic risk scores (PRS) has the potential to prevent nearly 25% of premature, preventable deaths.
Why It Matters:
PRS can identify individuals at high genetic risk for common chronic diseases like breast cancer, type 2 diabetes, and cardiovascular disease. This enables earlier, more personalized interventions—shifting the focus from age-based screenings to risk-based strategies.
The Impact:
Early Action Saves Lives: High-risk individuals can be screened up to 12.4 years earlier, catching diseases before they become life-threatening. Precision in Prevention: Lower-risk individuals can delay unnecessary screenings by up to 17.7 years, reducing healthcare burden. Transforming Public Health: This approach could prevent 24.5% of premature deaths, giving people more time with their loved ones and easing strain on healthcare systems.
The Bigger Picture:
Common chronic diseases account for over 90% of annual healthcare spending in the US, with one in five deaths considered preventable. Tailoring screening programs based on genetic risk could not only save lives but also revolutionize how we approach public health and resource allocation.